NewsBenzingaセレス・セラピューティクス、IDWeek 2026で、重篤患者の血流感染リスク低減を目的とした治験中の経口液体LBP「SER-428」の開発を支持する前臨床データを発表へ セレス・セラピューティクス、IDWeek 2026で、重篤患者の血流感染リスク低減を目的とした治験中の経口液体LBP「SER-428」の開発を支持する前臨床データを発表へ Benzinga 2026.10.15 11:07 (GMT+0) Open on Benzinga Other news Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.04 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15.1 Billion CoreWeave’s CEO Says the Market Doesn’t Understand His Company. Whether or Not It Does Isn’t What Matters Here. Chevron Stock Price Targets Are Up and Put Credit Spreads Are Attractive to Value Players Traders Give Google a 70% Chance of Having the Best AI Model. Most People Can’t Even Use It Yet. Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review Ahead of General Motors Earnings, Here's What Barchart Data Says Comes Next for GM Stock
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.04 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15.1 Billion
CoreWeave’s CEO Says the Market Doesn’t Understand His Company. Whether or Not It Does Isn’t What Matters Here.
